Volume 43, no. 4, p. 972–974, 1999. Page 972: The article byline should read as given above.
. 1999 Dec;43(12):3046.
Pharmacokinetics of Oral Zidovudine Entrapped in Biodegradable Nanospheres in Rabbits
Diana P Callender
1, Nalina Jayaprakash
1, Aaron Bell
1, Vidmantas Petraitis
1, Ruta PetraItiene
1, Myrna Candelario
1, Robert Schaufele
1, James M Dunn
1, Shizuko Sei
1, Thomas J Walsh
1, Frank M Balis
1
Diana P Callender
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by Diana P Callender
Nalina Jayaprakash
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by Nalina Jayaprakash
Aaron Bell
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by Aaron Bell
Vidmantas Petraitis
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by Vidmantas Petraitis
Ruta PetraItiene
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by Ruta PetraItiene
Myrna Candelario
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by Myrna Candelario
Robert Schaufele
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by Robert Schaufele
James M Dunn
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by James M Dunn
Shizuko Sei
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by Shizuko Sei
Thomas J Walsh
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by Thomas J Walsh
Frank M Balis
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Find articles by Frank M Balis
1Pediatric Oncology Branch and HIV and AIDS Malignancy Branch, Division of Clinical Science, National Cancer Institute, Bethesda, Maryland 20892, and Verex Laboratories, Inc., Englewood, Colorado 80112
Copyright © 1999, American Society for Microbiology
PMCID: PMC89617
This corrects the article "Pharmacokinetics of Oral Zidovudine Entrapped in Biodegradable Nanospheres in Rabbits" on page 972.